首页> 外文期刊>Journal of drug delivery science and technology >Design of a photocleavable drug binding platform for a novel remotely controllable drug coated balloon
【24h】

Design of a photocleavable drug binding platform for a novel remotely controllable drug coated balloon

机译:一种用于一种新型远程可控药物涂层气球的光纤维可爱药物绑定平台的设计

获取原文
获取原文并翻译 | 示例
           

摘要

Drug coated balloons have been emerging as alternatives to conventional devices such as drug eluting stents in the treatment of coronary artery stenosis. However, no coating method has been developed to deliver sufficient drug to the lesion. To enhance delivery efficiency- both by reducing the drug wash off under bloodstream and increasing transfer from balloon surface to the arterial wall, we have proposed a photocleavable drug binding platform, which securely bonds the drugs onto the balloon surface, and releases at the site of stenosis triggered by photoirradiation. As a proof of concept, we designed a model system by conjugating 3-amino-3-(2-nitro-phenyl) propionic acid (ANP) onto Cy5, the model drug, then conjugating this onto latex beads, which has a formulation similar to the materials used for conventional balloons. We confirmed its photoresponsivity and release efficiency by irradiating 365 nm light to trigger release and evaluated cellular uptake of Cy5 in vitro. Results proved that the proposed platform releases Cy5 when, and only when, it is triggered by photoirradiation, with drug wash off rate as low as 11% of the conventional DCB coatings in blood-filled environment. Our in vitro evaluation showed that the released substance remains functional and enters cells as designed. The proposed concept may provide a method of highly efficient remotely controllable topical drug delivery through various lumen-like tissues.
机译:在治疗冠状动脉狭窄的过程中,药物涂层球囊已经成为药物洗脱支架等传统设备的替代品。然而,目前还没有一种包衣方法能够向病变部位输送足够的药物。为了提高给药效率——通过减少血液中的药物冲刷和增加从球囊表面到动脉壁的转移,我们提出了一种可光降解的药物结合平台,该平台将药物安全地结合到球囊表面,并在光照射引发的狭窄部位释放。作为概念证明,我们设计了一个模型系统,将3-氨基-3-(2-硝基苯基)丙酸(ANP)结合到模型药物Cy5上,然后将其结合到乳胶珠上,乳胶珠的配方与传统气球所用的材料相似。我们通过照射365 nm的光来触发释放,并在体外评估细胞对Cy5的摄取,从而证实了其光响应性和释放效率。结果证明,当且仅当Cy5被光照触发时,该平台才会释放Cy5,在充满血液的环境中,药物清除率低至传统DCB涂层的11%。我们的体外评估表明,释放的物质仍具有功能,并按设计进入细胞。提出的概念可能提供一种通过各种管腔样组织进行高效远程可控局部药物递送的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号